Telotristat Etiprate (LX 1606 Hippurate) is an orally bioavailable, tryptophan hydroxylase (TPH) inhibitor with potential antiserotonergic activity. Phase 3.
Telotristat Etiprate (LX 1606 Hippurate) is an orally bioavailable, tryptophan hydroxylase (TPH) inhibitor with potential antiserotonergic activity. Phase 3.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Matthew H. Kulke,ey al. Telotristat Etiprate, a Novel Serotonin Synthesis Inhibitor, in Patients with Carcinoid Syndrome and Diarrhea Not Adequately Controlled by Octreotide. Endocr Relat Cancer. Author manuscript; available in PMC 2015 Apr 1. Published in final edited form as: Endocr Relat Cancer. 2014 Oct; 21(5): 705–714. Published online 2014 Jul 10. doi: 10.1530/ERC-14-0173.
[2] Kara Gross Margolis,et al. Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine. Gut. Author manuscript; available in PMC 2014 Jun 1. Published in final edited form as: Gut. 2014 Jun; 63(6): 928–937. Published online 2013 Jun 7. doi: 10.1136/gutjnl-2013-304901.
分子式 C36H35ClF3N7O6 |
分子量 754.15 |
CAS号 11137608-69-5 |
储存方式 -20 ℃长期冷藏储存。冰袋运输 |
溶剂(常温) |
DMSO 100 mg/mL |
Water <1 mg/mL |
Ethanol <1 mg/mL |
体内溶解度
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们